Loading cancer entity…
Loading cancer entity…
Clinical trials
805 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT04334837 | Copper Cu 64 Dotatate for the Detection, Localization and Monitoring of SSTR Expressing (NETs) | approved for marketing | — | — | Curium US LLCINDUSTRY | 0 | Oct 9, 2020 | clinicaltrials |
| NCT02705313 | EAP 177Lu-DOTA0-Tyr3-Octreotate for Inoperable, SSR+, NETs, Progressive Under SSA Tx | approved for marketing | — | — | Advanced Accelerator ApplicationsINDUSTRY | 1 | Apr 9, 2018 | clinicaltrials |
Data updated 22 days agoSource updated Oct 9, 2020source: clinicaltrials